Purpose: As endovascular stent graft repair of infrarenal abdominal aortic
aneurysms (AAAs) becomes more common, an increasing proportion of patients
who undergo open operation will have juxtarenal aneurysms (JR-AAAs), which
necessitate suprarenal crossclamping, suprarenal aneurysms (SR-AAAs), which
necessitate renal artery reconstruction, or aneurysms with associated rena
l artery occlusive disease (RAOD), which necessitate repair. To determine t
he current results of the standard operative treatment of these patterns of
pararenal aortic aneurysms, we reviewed the outcome of 257 consecutive pat
ients who underwent operation for JR-AAAs (n = 122), SR-AAAs (n = 58), or R
AOD (n = 77).
Methods: The patients with SR-AAAs and RAOD were younger (67.5 +/- 8.8 year
s) than were the patients with JR-AAAs (70.5 +/- 8.3 years), and more patie
nts with RAOD were women (43% vs 21% for JR-AAAs and SR-AAAs). The patient
groups were similar in the frequency of coronary artery and pulmonary disea
se and in most risk factors for atherosclerosis, except hypertension, which
was more common in the RAOD group. Significantly more patients with RAOD h
ad reduced renal function before surgery (51% vs 23%). Supravisceral aortic
crossclamping (above the superior mesenteric artery or the celiac artery)
was needed more often in patients with SR-AAAs (52% vs 39% for RAOD and 17%
for JR-AAAs). Seventeen patients (7%) had undergone a prior aortic reconst
ruction. The most common renal reconstruction for SR-AAA was reimplantation
(n = 37; 64%) or bypass grafting (n = 12; 21%) and for RAOD was transaorti
c renal endarterectomy (n = 71; 92%). Mean AAA. diameter n as 6.7 +/- 2.1 c
m and was larger in the JR-AAA. (7.1 +/- 2.1 cm) and SR-AAA (6.9 +/- 2.1 cm
) groups as compared with the RAOD group (5.9 +/- 1.7 cm).
Results: The overall mortality rate was 5.8% (n = 15) and was the same for
all the groups. The mortality rate correlated (P < .05) with hematologic co
mplications (bleeding) and postoperative visceral ischemia or infarction bu
t not with aneurysm group or cardiac, pulmonary, or renal complications. Re
nal ischemia duration averaged 31.6 +/- 21.6 minutes and was longer in the
SR-AAA group (43.6 +/- 38.9 minutes). Some postoperative renal function los
s occurred in 104 patients (40.5%), of whom 18 (7.0%) required dialysis. At
discharge or death, 24 patients (9.3%) still had no improvement in renal f
unction and 11 of those patients (4.3%) remained on dialysis. Postoperative
loss of renal function correlated (P < .05) with preoperative abnormal ren
al function and duration of renal ischemia but not with aneurysm type, cros
sclamp level, or type of renal reconstruction.
Conclusion: These results showed that pararenal AAA repair can be performed
safely and effectively. The outcomes for all three aneurysm types were sim
ilar, but there was an increased risk of loss of renal function when preope
rative renal function was abnormal. These data provide a benchmark for expe
cted treatment outcomes in patients with these patterns of pararenal aortic
aneurysmal disease that currently can only be managed with open repair.